累积终生雌激素暴露对绝经后女性类风湿关节炎临床特征及病程的影响
基于韩国关节炎观察研究网络队列的2878例绝经后类风湿关节炎女性,基线评估并随访5年,以中位数34年将累积终生雌激素暴露分为较高组与较低组。较低暴露组基线疾病活动度和影像学骨侵蚀更重、患者报告结局更差,5年内SDAI与HAQ-DI升高、EQ-5D效用值下降,基线SDAI>11者达到缓解的可能性更低(HR 0.597)。
要点
- 较低累积终生雌激素暴露组基线疾病活动度更高、影像学骨侵蚀更多、患者报告结局更差(均P<0.01)。
- 较低暴露组5年内SDAI与HAQ-DI升高、EQ-5D效用值下降。
- 基线SDAI>11者中较低暴露组达到缓解的可能性更低(HR 0.597,95%CI 0.421-0.848,p=0.004)。
核心结论
- 较低累积终生雌激素暴露的类风湿关节炎患者疾病活动度更高、骨侵蚀更重、患者报告结局更差。
- 较低累积终生雌激素暴露对疾病活动度和患者报告结局的纵向变化产生不利影响,并与达到临床缓解的可能性更低相关。
研究设计与样本
- 来自韩国关节炎观察研究网络队列的2878例绝经后女性类风湿关节炎患者,基线调查并随访5年。
- 累积终生雌激素暴露由生育期跨度与绝经后激素替代治疗时长合并计算,以中位数34年分为较高暴露组与较低暴露组。
主要发现
- 基线时较低暴露组(n=1602)疾病活动度显著高于较高暴露组(n=1179),影像学骨侵蚀更多。
- 基线时较低暴露组疼痛、疲劳、睡眠障碍、功能障碍、健康相关生活质量及类风湿关节炎总体评估等患者报告结局均差于较高暴露组(均P<0.01)。
- 校正混杂因素后,较低暴露组5年内SDAI和HAQ-DI评分升高、EQ-5D效用值下降。
- 基线SDAI>11的患者中,校正混杂因素后较低暴露组达到缓解的可能性显著更低(HR 0.597,95%CI 0.421-0.848,p=0.004)。
关键数值与推荐
- 累积终生雌激素暴露分组阈值:中位数34年。
- 较低暴露组n=1602,较高暴露组n=1179。
- 基线SDAI>11者中较低暴露组达到缓解的HR 0.597(95%CI 0.421-0.848,p=0.004)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the effect of cumulative lifetime estrogen exposure (CLEE) on the course of rheumatoid arthritis (RA). METHODS: A total of 2878 postmenopausal women with RA from the Korean Observational Study Network for Arthritis Cohort were investigated at baseline and followed for 5 years. CLEEs were calculated by combining the reproductive span and duration of postmenopausal hormone replacement therapy. Patients with RA were classified into higher and lower CLEE groups using a median of 34 years. RESULTS: Patients with RA and a lower CLEE (n = 1602) showed significantly higher disease activity and more radiographic erosion than those with a higher CLEE (n = 1179) at baseline. The lower CLEE group demonstrated worse patient-reported outcomes (PROs) for pain, fatigue, sleep disturbance, functional disability, health-related quality of life, and global assessment of RA than the higher CLEE group at baseline (all P < 0.01). The lower CLEE group showed increased Simplified Disease Activity Index (SDAI) and Health Assessment Questionnaire-Disability Index scores and decreased EQ-5D-utility values over 5 years after adjusting for confounders. Among patients with RA and an SDAI>11 at baseline, the lower CLEE group was significantly less likely to achieve remission after adjusting for confounders (HR, 0.597 [95% CI 0.421-0.848], p = 0.004). CONCLUSIONS: Patients with RA and lower CLEE had higher disease activity, more erosive disease, and worse PROs than those with a higher CLEE. Lower CLEE adversely affects longitudinal changes in disease activity and PROs and is associated with a lower likelihood of achieving clinical remission in RA.
引用
- Park EH, Choi ST, Song JS, et al. Effects of cumulative lifetime estrogen exposure on the clinical characteristics and courses in postmenopausal women with rheumatoid arthritis. Semin Arthritis Rheum. 2025. PMID: 40706261. doi:10.1016/j.semarthrit.2025.152790
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。